Abstract

Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base

Author(s): Friciu Mihaela, Benzina Ouafa, Hunt Kathryn, Cull Erica, LeClair Grégoire

Issue: Mar/Apr 2026 - Volume 30, Number 2

Page(s): 150-156

Download in electronic PDF format for $75
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 1
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 2
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 3
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 4
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 5
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 6
  • Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base Page 7

Abstract

Compounded Benzocaine (20%), Lidocaine (6%), and Tetracaine (4%) in VersaPro™ Cream Base was studied to evaluate the chemical, physical, and microbial stability over a 180-day period. Preparations were stored in ambient conditions in tightly closed, light-resistant, metered-dose plastic containers. An HPLC assay was developed and validated to assess chemical stability, while physical stability was assessed by observing organoleptic characteristics and measuring pH levels. Antimicrobial effectiveness testing was conducted according to USP <51> at the final stability time point. The results indicate that combined Benzocaine (20%), Lidocaine (6%), and Tetracaine (4%) compounded in VersaPro™ Cream Base was stable for the duration of the study and may be assigned an extended beyond-use-date of 180 days under the examined conditions.

Related Keywords

  • Benzocaine
  • Lidocaine
  • Tetracaine
  • BLT
  • Analgesic
  • Dermatology
  • Topical
  • Cream
  • VersaPro

Related Categories

  • PAIN MANAGEMENT
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2026
Pg. 150-156
Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base
Author(s): Friciu Mihaela, Benzina Ouafa, Hunt Kathryn, Cull Erica, LeClair Grégoire
Mar/Apr 2024
Pg. 133
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 50
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 266
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 156-160
Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit
Author(s): Friciu Mihaela, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jul/Aug 2020
Pg. 320
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Author(s): Allen Loyd V Jr
Nov/Dec 2023
Pg. 492
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 136
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 234
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 508-511
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
Author(s): McPherson Timothy B, Neumann William L, Kolling William M
Jul/Aug 2024
Pg. 310
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 476
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 44
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 416
Hydrocortisone 2% in Versapro Cream
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 303-304
Topical Oil-in-Water Cream Bases, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 98-102
Compounding Pearls -- Wound Care: Base Selection
Author(s): Riepl Mike
Jul/Aug 2021
Pg. 344-351
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Jul/Aug 2021
Pg. 336-343
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah